Translational Drug Development

Translational Drug Development CEO and Key Executive Team

Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.

Translational Drug Development's President and CEO is Stephen Gately. Translational Drug Development's key executives include Stephen Gately and 7 others.

Source: td2inc.com, td2inc.com, td2inc.com

Cerba Research
Healthcare - Subsidiary
FibroGen
Healthcare - Public
Sinergium Biotech
Healthcare - Private
Lineage Cell Therapeutics
Healthcare - Public

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Learn more

Translational Drug Development CEO and Key Executive Team

Stephen Gately

Tara Franks

Eric Tooker

Jennifer Keppler

Susan Tessmann

Chad Souvignier

Shaun A. Kirkpatrick

Daniel Von Hoff

Need Data?

Footer menu

Product

Solutions

Resources

Company

Translational Drug Development CEO and Key Executive Team

Stephen Gately

Tara Franks

Eric Tooker

Jennifer Keppler

Susan Tessmann

Chad Souvignier

Shaun A. Kirkpatrick

Daniel Von Hoff

Executives of similar companies

Need Data?

Footer menu

Product

Solutions

Resources

Company